Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

Buyout Rumors?-

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
bellweather1 Member Profile
Member Level 
Followed By 9
Posts 2,364
Boards Moderated 0
Alias Born 06/08/10
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/17/2014 4:23:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/16/2014 4:26:18 PM
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results "Business Wire" - 10/15/2014 7:35:00 AM
ARIAD rende nota la raccomandazione per Iclusig da parte del Comitato di valutazione dei rischi per la farmacovigilanza dell'... "Business Wire" - 10/10/2014 3:43:00 PM
Ariad annonce les recommandations du comité pour l’évaluation des risques en matière de pharmacovigilance de l’Agence ... "Business Wire" - 10/10/2014 10:12:00 AM
ARIAD erhält befürwortende Stellungnahme für Iclusig vom Beratenden Ausschuss für Risikobewertung im Bereich der Pharmako... "Business Wire" - 10/10/2014 7:49:00 AM
ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency "Business Wire" - 10/10/2014 7:44:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/10/2014 6:00:32 AM
ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology "Business Wire" - 10/6/2014 7:35:00 AM
AP26113 d’ARIAD désigné par la FDA traitement révolutionnaire contre le cancer bronchique non à petites cellules ALK+ r... "Business Wire" - 10/3/2014 12:24:00 PM
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer Resistant to Crizotinib "Business Wire" - 10/2/2014 7:35:00 AM
ARIAD présente de nouveaux résultats de son étude clinique sur l'AP26113 chez des patients atteints d'un cancer du poumon ... "Business Wire" - 9/30/2014 10:18:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/29/2014 4:05:48 PM
ARIAD Presents Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer "Business Wire" - 9/29/2014 7:35:00 AM
ARIAD stellt aktualisierte klinische Ergebnisse zu AP26113 bei Patienten mit ALK-positivem nicht-kleinzelligem Lungenkrebs vor "Business Wire" - 9/29/2014 7:35:00 AM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 9/18/2014 4:30:05 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/18/2014 4:06:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/11/2014 4:41:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/11/2014 4:39:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/11/2014 4:38:33 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 9/5/2014 4:52:47 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 9/5/2014 4:48:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/4/2014 4:24:18 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/4/2014 4:23:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/4/2014 4:21:24 PM
bellweather1 Member Level  Wednesday, 10/19/11 01:37:42 PM
Re: bellweather1 post# 13354
Post # of 55383 
Buyout Rumors?-

Looks like we're running up in tandem with HGSI(+15.2%) and DNDN(+5.75%) today.

Yesterday's HGSI speculation may be driving us(in addition to the breakout) along with others viewed by some as attractive takeover candidates.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist